Vol 13, No 7 (July 30, 2024) - Translational Lung Cancer Research

Original Article

Immunohistochemistry identifies E-cadherin, N-cadherin and focal adhesion kinase (FAK) as predictors of stage I non-small cell lung carcinoma spread through the air spaces (STAS), and the combinations as prognostic factors

Yunchang Meng, Yimin Wang, Leilei Liu, Ranpu Wu, Qingfeng Zhang, Zhangxuan Chen, Yang Yao, Xinjing Li, Yanzhuo Gong, Huijuan Li, Zhaofeng Wang, Hongbing Liu

Translational Lung Cancer Research

2024;

(7)

:1450-1462

(30 July 2024)

PDF Full Text (2240) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

PD-L1 expression from surgically resected lung tumors predictive of early progression in patients previously treated with targeted therapy for initially unresectable non-small cell lung cancer

Jeong Uk Lim, Hye Seon Kang, Mi Hyoung Moon, Chang Dong Yeo, Young Jo Sa, Tae-Jung Kim, Deog Gon Cho, Kyung Soo Kim

Translational Lung Cancer Research

2024;

(7)

:1463-1480

(30 July 2024)

PDF Full Text (1220) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Differential impact of intratumor heterogeneity (ITH) on survival outcomes in early-stage lung squamous and adenocarcinoma based on tumor mutational burden (TMB)

Stanislav Fridland, Hye Sung Kim, Young Kwang Chae

Translational Lung Cancer Research

2024;

(7)

:1481-1494

(30 July 2024)

PDF Full Text (1125) Reporting Checklist Peer Review File COI Form Open Access

Omission of staging PET/CT linked to reduced survival in stage III non-small cell lung cancer: insights from the LUCAS project real-world data

Gabriela Krakorova, Petr Domecky, Jiri Blazek, Milos Pesek, Ondrej Venclicek, Libor Havel†, Michal Hrnciarik, Jana Krejci, Andrea Mullerova, Miloslav Marel, Jaroslav Duba, Martin Svaton

Translational Lung Cancer Research

2024;

(7)

:1495-1504

(30 July 2024)

PDF Full Text (1282) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Real-world biomarker testing patterns: clinical-pathological portrait of early and late non-small cell lung cancer in hub and spoke North Italian centers

Mariaenrica Tinè, Federica Pezzuto, Manuela Orlandi, Anna Caliò, Stefano Marletta, Tommaso Bondavalli, Diego Giongo, Daniela Reghellin, Ilaria Posenato, Maria Santacatterina, Andrea Menin, Patrick Karl Welte, Francesca Baciorri, Diana Sacchi, Cosimo Catino, Lorenzo Nicolè, Gabriele Foltran, Alessandra D’Urso, Nicla Orzes, Giulia Andreotti, Patrizia Bartolotta, Dario Gregori, Giulia Pasello, Federico Rea, Fiorella Calabrese

Translational Lung Cancer Research

2024;

(7)

:1505-1517

(30 July 2024)

PDF Full Text (1524) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Comparative efficacy and safety of anlotinib and topotecan as second-line treatment in small cell lung cancer: a retrospective cohort study

Yang Du, Xiao-Yan Liu, Xiao-Yan Si, Xiao-Tong Zhang, Jing-Ya Zhou, Yi Wang, Min-Jiang Chen, Li Zhang

Translational Lung Cancer Research

2024;

(7)

:1518-1529

(30 July 2024)

PDF Full Text (1062) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Lymph node dissection of station 8 improves the survival of T_{≤3 cm}N0M0 lung adenocarcinoma patients

Tengyong Wang, Zihuai Wang, Hui Jie, Chengwu Liu, Shiyou Wei, Hu Liao, Jiandong Mei, Qiang Pu, Lunxu Liu

Translational Lung Cancer Research

2024;

(7)

:1530-1543

(30 July 2024)

PDF Full Text (884) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Association between thymus density loss and efficacy in non-small cell lung cancer patients treated with immune checkpoint inhibitors

Yi Li, Bingxin Gong, Jie Lou, Yusheng Guo, Bo Liang, Weiwei Liu, Ziang You, Chao Chen, Bin Chai, Shanshan Jiang, Hongyong Zhang, Feng Pan, Lian Yang, Guofeng Zhou

Translational Lung Cancer Research

2024;

(7)

:1544-1558

(30 July 2024)

PDF Full Text (1727) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Prognostic relevance of immune-related adverse events in lung cancer patients undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis

Yuchen Huang, Wananqi Ma, Dongsheng Wu, Mengyuan Lyu, Quan Zheng, Tengyong Wang, Jian Zhou, Chengwu Liu

Translational Lung Cancer Research

2024;

(7)

:1559-1584

(30 July 2024)

PDF Full Text (1868) Reporting Checklist Peer Review File COI Form Open Access

Durvalumab plus platinum-etoposide chemotherapy for extensive-stage small cell lung cancer: a retrospective real-world study

Kazuhito Misawa, Kageaki Watanabe, Masahiro Seike, Yukio Hosomi

Translational Lung Cancer Research

2024;

(7)

:1585-1594

(30 July 2024)

PDF Full Text (2325) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Evaluating three-dimensional lung reconstructions for thoracoscopic lung resections using open-source software: a pilot study

Iris E. W. G. Laven, Vincent P. S. Oosterhoff, Aimée J. P. M. Franssen, Lori M. van Roozendaal, Karel W. E. Hulsewé, Yvonne L. J. Vissers, Erik R. de Loos

Translational Lung Cancer Research

2024;

(7)

:1595-1608

(30 July 2024)

PDF Full Text (1321) Reporting Checklist Trial Protocol Data Sharing Statement Peer Review File COI Form Open Access

Resected lung adenocarcinoma with lymph node metastasis: is ground glass opacity component a prognostic factor?

Chaoqiang Deng, Chenyu Jiang, Xiangyi Ma, Fangqiu Fu, Shengping Wang, Yuan Li, Yang Zhang, Haiquan Chen

Translational Lung Cancer Research

2024;

(7)

:1609-1619

(30 July 2024)

PDF Full Text (1294) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Immune checkpoint inhibitors as subsequent treatment in older adults with non-small cell lung cancer and synchronous brain metastases

Ruchira V. Mahashabde, Sajjad A. Bhatti, Bradley C. Martin, Jacob T. Painter, Analiz Rodriguez, Jun Ying, Chenghui Li

Translational Lung Cancer Research

2024;

(7)

:1620-1634

(30 July 2024)

PDF Full Text (1557) Reporting Checklist Peer Review File COI Form Open Access

Timing of stereotactic radiosurgery within the first-line systemic treatment in non-small cell lung cancer brain metastases: a retrospective single-center cohort study

Raphael Bodensohn, Anna Kolorz, Jonas Reis, Simone Werner, Robert Forbrig, Sylvia Garny, Julian Taugner, Chiara de Colle, Claus Belka, Farkhad Manapov, Louisa von Baumgarten, Maximilian Niyazi

Translational Lung Cancer Research

2024;

(7)

:1635-1648

(30 July 2024)

PDF Full Text (1652) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Real-world efficacy of low dose osimertinib as second-line treatment in patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer

Mau Ern Poh, Sivasubramaniam Balakrishnan, Sin Nee Tan, Muhammad Adil Zainal Abidin, Chong Kin Liam, Jiunn Liang Tan, Yong Kek Pang, Arvindran Alaga, Lye Mun Tho, Soon Hin How

Translational Lung Cancer Research

2024;

(7)

:1649-1659

(30 July 2024)

PDF Full Text (2740) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

PD-L1 expression in non-small cell lung carcinoma in Latin America: a systematic review and meta-analysis

Rafael Parra-Medina, Juan Pablo Castañeda-González, Luisa Montoya, María Paula Gómez-Gómez, Daniel Clavijo Cabezas, Merideidy Plazas Vargas

Translational Lung Cancer Research

2024;

(7)

:1660-1671

(30 July 2024)

PDF Full Text (1965) Reporting Checklist Peer Review File COI Form Open Access

Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study

Haohua Jiang, Yujing Li, Yanan Wang, Benkun Zou, Ya Chen, Yanwei Zhang, Hatim Husain, Fabien Forest, Fangfei Qian, Lele Zhang, Chao Zhou, Hongyu Liu, Danni Wang, Wei Zhang, Jun Lu, Baohui Han

Translational Lung Cancer Research

2024;

(7)

:1672-1684

(30 July 2024)

PDF Full Text (1743) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Sublobar resection for lung adenocarcinoma less than 2 cm containing solid or micropapillary components radiologically presented as consolidation-to-tumor ratio (CTR) ≤0.25 [ground-glass opacity (GGO)]

Mingyang Zhu, Yuanyuan Xu, Jiazheng Huang, Yaxian Yao, Davide Tosi, Terumoto Koike, Nestor R. Villamizar, Ziang Wang, Feng Mao, Qingquan Luo, Qiang Tan

Translational Lung Cancer Research

2024;

(7)

:1685-1694

(30 July 2024)

PDF Full Text (1220) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Efficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with leptomeningeal metastases harboring targetable mutations

Xiaoyu Ji, Rongrong Jiang, Tao Liu, Mariano Provencio, Sang Chul Lee, Qiong Zhan, Xinli Zhou

Translational Lung Cancer Research

2024;

(7)

:1695-1707

(30 July 2024)

PDF Full Text (959) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Tumor cavitation in patients with non-small-cell lung cancer receiving anti-angiogenic therapy with apatinib

Qian Cai, Kui Hu, Shuang Dong, Xiaoyu Li, Sheng Hu, Wenyou Deng, Wulin Ou

Translational Lung Cancer Research

2024;

(7)

:1708-1717

(30 July 2024)

PDF Full Text (1375) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Age at first sexual intercourse, age at menarche, and age at menopause: a mendelian randomization study on lung cancer risk

Yifan Liu, Xinxin Ying, Yao Li, Xingyu Zhu, Wangwei Jing, Xiaohong Wang, Zhengfu He

Translational Lung Cancer Research

2024;

(7)

:1718-1726

(30 July 2024)

PDF Full Text (2243) Reporting Checklist Peer Review File COI Form Open Access

miR-16-5p specifically inhibits IFN-γ-regulated memory T helper cell differentiation in malignant pleural effusion of non-small cell lung cancer

Yi Sun, Xiaofen Qiu, Dalei Zhou, Sara Ricciardi, Shuichi Shinohara, Jiangjun Ma

Translational Lung Cancer Research

2024;

(7)

:1727-1741

(30 July 2024)

PDF Full Text (1228) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Case Report

Pathological complete response to neoadjuvant lorlatinib in a patient with stage IIIA ALK-positive non-small cell lung cancer: a case report

Li Lu, Zhengqi Cao, Anni Wang, Lixuan Chen, Jing Sun, Ziming Li

Translational Lung Cancer Research

2024;

(7)

:1742-1748

(30 July 2024)

PDF Full Text (1340) Reporting Checklist Peer Review File COI Form Open Access

Intracranial response to capmatinib after progression on crizotinib in a patient with MET exon 14 skipping non-small cell lung cancer—a case report

Balázs Jóri, Otto Bundschuh, Markus Falk, Lukas C. Heukamp, Alexander Kluge, Markus Tiemann, Kay C. Willborn, Johannes Woitzik, Frank Griesinger

Translational Lung Cancer Research

2024;

(7)

:1749-1755

(30 July 2024)

PDF Full Text (1291) Reporting Checklist Peer Review File COI Form Open Access

Transcriptomic profiling of a late recurrent nuclear protein in testis carcinoma of the lung 14 years after the initial operation: a case report

Taketo Kato, Hironori Oyamatsu, Yuki Hanamatsu, Heng Huang, Shoji Okado, Yoshito Imamura, Yuji Nomata, Hiroki Watanabe, Yuka Kadomatsu, Harushi Ueno, Shota Nakamura, Tetsuya Mizuno, Tetsunari Hase, Tamotsu Takeuchi, Toyofumi Fengshi Chen-Yoshikawa

Translational Lung Cancer Research

2024;

(7)

:1756-1762

(30 July 2024)

PDF Full Text (1188) Reporting Checklist Peer Review File COI Form Open Access

Vol 13, No 7 (July 30, 2024): Translational Lung Cancer Research

Original Article

Case Report